CellSolutions is comprised of experienced professionals who have spent the past two decades innovating, standardizing and improving all aspects of technologies that enhance the quality of cytology preparation, cell presentation, screening and diagnostic interpretation. Dedicated experts from the fields of cytology, chemistry, computer-based image analysis and software engineering, supported by significant expertise from both universities and industry, have joined the CellSolutions effort to create truly innovative cytology products for the world.
Ernest A. Knesel
President and CEO
Mr. Knesel was a founder and officer in charge of operations for Biomedical Reference Laboratories, Inc., which started in 1969 and went public in 1979. Biomedical Reference Laboratories was at this time the most successful of the publicly traded clinical laboratories. Mr. Knesel served as Senior Vice President of this business and its successor company Roche Biomedical Laboratories, Inc. through 1995. From 1969 through 1995 the business grew from a start up enterprise to a company with $1 billion in revenue.
During his tenure in his position as Senior Vice President, Mr. Knesel’s responsibilities included strategic planning, laboratory direction, and management of operations, laboratory acquisitions and extensive regional/national organizational development. Mr. Knesel was responsible as the chief scientific officer for laboratory technology selection, innovation and development for all areas of the clinical laboratory. Mr. Knesel has had extensive experience in sales, marketing and has demonstrated an acute awareness of market needs and its priorities. He personally developed and directed a variety of highly successful differentiating niche businesses within Roche Biomedical Laboratories, which merged to create Laboratory Corporation of America in 1995.
In 1989 Mr. Knesel founded Roche Image Analysis Systems (RIAS) as a subsidiary of Roche Biomedical Laboratories and successfully established this company as a leader in automated cytodiagnostics. As the President of RIAS, Mr. Knesel and his team of cyto-professionals developed a new automated thin-layer cell preparation to improve the Pap smear and directed technology acquisitions and product development for microscopic cell based image analysis. Mr. Knesel was also founder and first president of AutoCyte, Inc. the successor to RIAS established with venture capital backing in 1996 and taken public in 1997. Mr. Knesel was responsible for planning, direction and oversight of AutoCyte’s successful PMA approval and gained significant experience working with the FDA, Office of Device Evaluation, in this and related efforts. Mr. Knesel and his team were instrumental in the merger of technologies from Autocyte, Neopath and Neuromedical Systems creating Tripath Imaging in 1999.
Mr. Knesel received a BS in Biology and Medical Technology and an MS in Biochemistry from Fairleigh Dickinson University.